Ehv-4 glycoprotein vaccine

Details Ehv-4 glycoprotein vaccine Ehv-4 glycoprotein vaccine

C - Chemistry, Metallurgy

12

N

C12N 15/38 (2006.01) A61K 39/27 (2006.01) A61K 39/42 (2006.01) C07K 4/02 (2006.01) C07K 14/03 (2006.01) C07K 16/08 (2006.01) C12N 5/10 (2006.01) C12N 7/01 (2006.01) C12N 15/86 (2006.01) C12P 21/08 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2086739

2086739 9201057 PCTABS00010 The invention is concerned with the glycoproteins gH and gC of EHV-4 which can be used to vaccinate horses against EHV-4 infection. The invention also relates to nucleic acid sequences encoding the EHV-4 gH and gC polypeptides. Said sequences can be used for the preparation of a subunit or vector vaccine.

Affiliated with

Also associated with

Rating

Ehv-4 glycoprotein vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ehv-4 glycoprotein vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ehv-4 glycoprotein vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2017103